SG Americas Securities LLC Buys 22,087 Shares of Encompass Health Corporation (NYSE:EHC)

SG Americas Securities LLC lifted its position in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 737.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 25,084 shares of the company's stock after buying an additional 22,087 shares during the period. SG Americas Securities LLC's holdings in Encompass Health were worth $2,541,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. US Bancorp DE boosted its position in Encompass Health by 9.6% during the 4th quarter. US Bancorp DE now owns 1,380 shares of the company's stock worth $127,000 after acquiring an additional 121 shares during the last quarter. Signaturefd LLC boosted its holdings in Encompass Health by 21.6% during the fourth quarter. Signaturefd LLC now owns 704 shares of the company's stock worth $65,000 after purchasing an additional 125 shares during the last quarter. CBIZ Investment Advisory Services LLC grew its position in Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after purchasing an additional 127 shares in the last quarter. CIBC Asset Management Inc increased its stake in Encompass Health by 5.2% in the 4th quarter. CIBC Asset Management Inc now owns 3,111 shares of the company's stock valued at $287,000 after buying an additional 154 shares during the last quarter. Finally, SPC Financial Inc. boosted its stake in shares of Encompass Health by 0.3% during the 4th quarter. SPC Financial Inc. now owns 45,077 shares of the company's stock worth $4,163,000 after buying an additional 154 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Encompass Health

In other news, insider Elissa Joy Charbonneau sold 4,279 shares of the business's stock in a transaction dated Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total value of $498,974.19. Following the transaction, the insider now directly owns 11,958 shares of the company's stock, valued at $1,394,422.38. The trade was a 26.35% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Mark J. Tarr sold 118,384 shares of the company's stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total value of $14,387,207.52. Following the sale, the chief executive officer now owns 527,070 shares in the company, valued at approximately $64,054,817.10. The trade was a 18.34% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 132,663 shares of company stock worth $16,034,082. Insiders own 2.10% of the company's stock.

Encompass Health Price Performance

Shares of NYSE:EHC traded up $1.29 during trading on Wednesday, reaching $120.48. 220,772 shares of the company traded hands, compared to its average volume of 702,055. The company's 50 day moving average is $114.79 and its two-hundred day moving average is $103.63. The firm has a market capitalization of $12.14 billion, a PE ratio of 24.89, a PEG ratio of 2.45 and a beta of 0.89. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.81. Encompass Health Corporation has a 52 week low of $82.74 and a 52 week high of $123.13.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.18. Encompass Health had a return on equity of 17.63% and a net margin of 8.97%. The company had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. During the same quarter last year, the business posted $1.12 EPS. Encompass Health's revenue for the quarter was up 10.6% on a year-over-year basis. As a group, sell-side analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.56%. The ex-dividend date is Tuesday, July 1st. Encompass Health's payout ratio is presently 14.05%.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Stephens raised Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 target price on the stock in a research report on Thursday, June 5th. Royal Bank Of Canada upped their price objective on Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research note on Monday, April 28th. Truist Financial reissued a "buy" rating and issued a $135.00 target price (up from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. UBS Group upped their price target on shares of Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. Finally, KeyCorp lifted their price objective on shares of Encompass Health from $122.00 to $135.00 and gave the company an "overweight" rating in a research report on Tuesday, May 27th. Eight equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, Encompass Health presently has a consensus rating of "Buy" and a consensus target price of $127.00.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.